| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |